Accretion Nutraveda Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 3,000 shares,. Its Average Traded Price (ATP) is ₹271.46, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1000 @ ₹270.00.
Accretion Nutraveda has an upper circuit limit of ₹338.40 and a lower circuit limit of ₹225.60. The total value traded stands at ₹8.14 L, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 1000. Accretion Nutraveda also offers a dividend yield of 0%.
Accretion Nutraveda Share Price Chart
Accretion Nutraveda Share Key Metrics
Volume
3000.00
Market Cap
195.48 CR
LTQ@LTP
1000@270.00
ATP
271.46
Var Margin
53.5 %
Circuit Range
225.6-338.4
Delivery %
- %
Value
8.14 L
ASM/GSM
No
Market Lot
1000
Accretion Nutraveda Resistance and Support
Pivot 281.6
Resistance
First Resistance
282.4
Second Resistance
282.8
Third Resistance
283.6
Support
First Support
281.2
Second Support
280.4
Third Support
280
Accretion Nutraveda Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-08 | Audited Results |
Accretion Nutraveda News
Accretion Nutraveda Ltd - 544694 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Accretion Nutraveda announced a postal ballot for five special resolutions. These include expanding its MOA to broaden business scope, increasing borrowing limits to ₹500 crores, and approving inter-corporate loans/guarantees/investments up to ₹100 crores to support future growth and operations.
Sep 09 2026 21:19:13
Accretion Nutraveda Ltd - 544694 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Accretion Nutraveda's Board approved significant changes to its Memorandum of Association, expanding its business scope across healthcare, pharma, and agriculture. The board also increased borrowing and charge creation limits, along with approvals for loans/guarantees to interested parties, all subject to shareholder consent.
Sep 02 2026 15:37:39
Accretion Nutraveda Ltd - 544694 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Accretion Nutraveda's board approved a strategic expansion of its business activities by altering its Memorandum of Association. The company also secured approval for higher borrowing and security creation limits, enhancing its financial flexibility, all subject to shareholder consent.
Sep 01 2026 12:43:43
Accretion Nutraveda Ltd - 544694 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Accretion Nutraveda's Board approved several key proposals including altering the Object Clause in its MOA, increasing borrowing limits under Section 180(1)(c), and enhancing limits for creating charges under Section 180(1)(a). These actions aim to boost the company's financial and operational flexibility, subject to shareholder approval via postal ballot.
Sep 01 2026 12:39:49
Accretion Nutraveda Management
| Name | Position |
|---|---|
| Mayur Popatlal Sojitra | Managing Director |
| Ankurkumar Patel | Whole Time Director |
Accretion Nutraveda FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in ANL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC